NDC 17156-525 - DMSA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17156-525
- Package NDCs from labels
- 17156-525-01
- Manufacturer
- GE Healthcare
- Effective date
- 2007-08-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DMSA - GE Healthcare | GE Healthcare | 2007-08-03 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17156-525-01 | DMSA | 5 in 1 BOX | INJECTION, POWDER, LYOPHILIZED, | 5 | 2 | |
| 17156-525-01 | DMSA | 1 in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 1 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Dimercaptocuccinic Acid | ACTIVE INGREDIENT | 4S9JU7XF01 | DMSA (DIMERCAPTOSUCCINIC ACID) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GE HEALTHCARE] | 2 | |
| Dimercaptocuccinic Acid | ACTIVE MOIETY | 4S9JU7XF01 | DMSA (DIMERCAPTOSUCCINIC ACID) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GE HEALTHCARE] | 2 | |
| ascorbic acid | INACTIVE INGREDIENT | PQ6CK8PD0R | DMSA (DIMERCAPTOSUCCINIC ACID) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GE HEALTHCARE] | 2 | |
| inositol | INACTIVE INGREDIENT | 4L6452S749 | DMSA (DIMERCAPTOSUCCINIC ACID) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GE HEALTHCARE] | 2 | |
| Stannous Chloride Dihydrate | INACTIVE INGREDIENT | 1BQV3749L5 | DMSA (DIMERCAPTOSUCCINIC ACID) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [GE HEALTHCARE] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ascorbic Acid | ASCORBIC ACID | Renova Pharmaceuticals LLC | a6481bae-2397-44c7-a51d-4f47ad91bd2c | 2026-08-19 | Warnings, Adverse reactions | Ascorbic Acid |
| CLARISCAN | GADOTERATE MEGLUMINE | GE Healthcare | c9e273b3-481f-4899-8913-95aaddcc7662 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | GE Healthcare |
| CLARISCAN | GADOTERATE MEGLUMINE | GE Healthcare | 6f8c9fac-c995-4bf4-950d-ab89deb291b5 | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | GE Healthcare |
| Omnipaque | IOHEXOL | GE Healthcare | 164b27b9-97ae-4279-896f-1c4afa583dd1 | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | GE Healthcare |
| Ascorbic Acid | ASCORBIC ACID | Fresenius Kabi USA, LLC | 1606e29f-0e80-4069-b688-daab9cbff20a | 2025-12-17 | Warnings, Adverse reactions | Ascorbic Acid |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.